GeoVax Labs Inc (GOVX) - Financial and Strategic SWOT Analysis Review

July 2021 | 48 pages | ID: GA649C502CDEN
GlobalData

Abstracts

GeoVax Labs Inc (GOVX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

GeoVax Labs Inc (GeoVax) is a biotechnology company that develops immunotherapies and vaccines against cancers and various infectious diseases. GeoVax develops vaccines using its novel patented Modified Vaccinia Ankara-Virus like Particle (MVA-VLP) vector vaccine platform focused on therapy areas such as infectious diseases like HIV, Lassa fever, Ebola, Zika virus, malaria, Hepatitis B, coronavirus, and cancers related to solid tumors and HPV-associated head and neck cancer. The company has partnerships for preclinical and clinical testing with various government, academic and corporate entities, including Centers for Disease Control and Prevention (CDC), Leidos Inc, Scripps Research Institute, and Emory University. GeoVax is headquartered in Smyrna, Georgia, the US.

GeoVax Labs Inc Key Recent Developments

Jun 10,2021: GeoVax to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium
May 06,2021: GeoVax Reports 2021 First Quarter Financial Results and Provides Corporate Update
Mar 23,2021: GeoVax reports 2020 year-end financial results and provides corporate update
Mar 17,2021: GeoVax to Participate in Benzinga Biotech Small Cap Conference
Mar 15,2021: GeoVax to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

GeoVax Labs Inc - Key Facts
GeoVax Labs Inc - Key Employees
GeoVax Labs Inc - Key Employee Biographies
GeoVax Labs Inc - Major Products and Services
GeoVax Labs Inc - History
GeoVax Labs Inc - Company Statement
GeoVax Labs Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
GeoVax Labs Inc - Business Description
R&D Overview
GeoVax Labs Inc - Corporate Strategy
GeoVax Labs Inc - SWOT Analysis
SWOT Analysis - Overview
GeoVax Labs Inc - Strengths
GeoVax Labs Inc - Weaknesses
GeoVax Labs Inc - Opportunities
GeoVax Labs Inc - Threats
GeoVax Labs Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
GeoVax Labs Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Jun 10, 2021: GeoVax to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium
May 06, 2021: GeoVax Reports 2021 First Quarter Financial Results and Provides Corporate Update
Mar 23, 2021: GeoVax reports 2020 year-end financial results and provides corporate update
Mar 17, 2021: GeoVax to Participate in Benzinga Biotech Small Cap Conference
Mar 15, 2021: GeoVax to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update
Mar 10, 2021: GeoVax to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference
Mar 04, 2021: GeoVax expands and strengthens intellectual property portfolio
Mar 03, 2021: GeoVax to Present at the H.C. Wainwright Global Life Sciences Conference
Mar 01, 2021: Registration now open for Tribe Public’s webinar event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” featuring GeoVax’s CEO & CFO On March 3, 2021
Jan 05, 2021: GeoVax to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

GeoVax Labs Inc, Key Facts
GeoVax Labs Inc, Key Employees
GeoVax Labs Inc, Key Employee Biographies
GeoVax Labs Inc, Major Products and Services
GeoVax Labs Inc, History
GeoVax Labs Inc, Subsidiaries
GeoVax Labs Inc, Key Competitors
GeoVax Labs Inc, Ratios based on current share price
GeoVax Labs Inc, Annual Ratios
GeoVax Labs Inc, Annual Ratios (Cont...1)
GeoVax Labs Inc, Interim Ratios
GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
GeoVax Labs Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

GeoVax Labs Inc, Performance Chart (2016 - 2020)
GeoVax Labs Inc, Ratio Charts
GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021